VOR
Vor Biopharma·NASDAQ
--
--(--)
--
--(--)
3.84 / 10
Netural
Analyst consensus is overwhelmingly bullish (Buy 100%), though only one recent rating exists. Fund‑flow metrics are strong, with overall, block and extra‑large inflows positive, while small, medium and large categories show outflows. Sentiment score is solid, yet the mixed picture calls for prudence.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Sadia RahmanBuy
Date2026-03-19
InstitutionWells Fargo
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for VOR?
- VOR holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.84/10 (Netural).
